Video retinal imaging specialist听Epipole听has听secured 拢1.5m听in new funding to prepare for introduction into the United States ophthalmic imaging market.听听
The financing was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.听听
Epipole听also announced the appointment of Ian Stevens as Chairman.听
Founded by Dr Craig Robertson and award-winning optical engineer Bob Henderson in 2011,听Epipole听is a registered medical device business which designs, manufactures and markets portable video retinal imaging technology.听听
贰辫颈辫辞濒别鈥檚听technology enables clinicians to scan the retina using real-time video and then extract high–quality images for further examination.听听
Retinal cameras听have听typically听been听large and costly desktop systems, but听Epipole听said听it can听鈥�revolutionise the sector鈥�听with听a new听portable听design.听
鈥淲e鈥檝e worked with ophthalmologists to test and refine features and听capabilities, and听will use this funding to implement the key changes needed,鈥� said Dr Craig Robertson, founder and CEO of听Epipole.听听
鈥淲e will have a particular focus on the US primary care optometry and ophthalmology markets, and plan to have product available by early 2021.鈥�听
鈥淚 am pleased to welcome Ian Stevens as chairman,鈥� added Robertson. 鈥淗is broad commercial experience and specific expertise in retinal imaging will be valuable to us as we introduce our products to the eyecare market.鈥澨�
The new appointment听is an experienced technology industry executive, holding CEO positions at Scottish businesses Touch Bionics,听Mpathy听Medical and听BioFilm.听听
Previously, he spent nine years at leading retinal imaging company听Optos, initially as CFO and then as General Manager of its North American business.听
鈥淭here is a tremendous opportunity for handheld and truly portable fundus cameras that are easy to use and combine high quality imaging with attractive pricing,鈥� said Stevens.听听
鈥淚 am delighted to join the company and look forward to working with Craig and his team as we seek to transform ophthalmic imaging with our new technology.鈥�听